Carmen Bertoni - Search Results

Year	Number of Results
2002	1
2003	1
2004	1
2005	2
2006	2
2008	1
2009	2
2010	1
2011	1
2012	1
2013	2
2014	6
2016	1
2019	1
2024	0

1

Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy.

Namgoong JH, Bertoni C. Namgoong JH, et al. Among authors: bertoni c. Degener Neurol Neuromuscul Dis. 2016 May 13;6:37-48. doi: 10.2147/DNND.S71808. eCollection 2016. Degener Neurol Neuromuscul Dis. 2016. PMID: 30050367 Free PMC article. Review.

2

Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells.

Bertoni C. Bertoni C. Front Physiol. 2014 Apr 21;5:148. doi: 10.3389/fphys.2014.00148. eCollection 2014. Front Physiol. 2014. PMID: 24795643 Free PMC article. Review.

3

High throughput screening in duchenne muscular dystrophy: from drug discovery to functional genomics.

Gintjee TJ, Magh AS, Bertoni C. Gintjee TJ, et al. Among authors: bertoni c. Biology (Basel). 2014 Nov 14;3(4):752-80. doi: 10.3390/biology3040752. Biology (Basel). 2014. PMID: 25405319 Free PMC article. Review.

4

Clinical approaches in the treatment of Duchenne muscular dystrophy (DMD) using oligonucleotides.

Bertoni C. Bertoni C. Front Biosci. 2008 Jan 1;13:517-27. doi: 10.2741/2697. Front Biosci. 2008. PMID: 17981565 Review.

5

Targeting a therapeutic LIF transgene to muscle via the immune system ameliorates muscular dystrophy.

Welc SS, Flores I, Wehling-Henricks M, Ramos J, Wang Y, Bertoni C, Tidball JG. Welc SS, et al. Among authors: bertoni c. Nat Commun. 2019 Jun 26;10(1):2788. doi: 10.1038/s41467-019-10614-1. Nat Commun. 2019. PMID: 31243277 Free PMC article.

6

Nonaminoglycoside compounds induce readthrough of nonsense mutations.

Du L, Damoiseaux R, Nahas S, Gao K, Hu H, Pollard JM, Goldstine J, Jung ME, Henning SM, Bertoni C, Gatti RA. Du L, et al. Among authors: bertoni c. J Exp Med. 2009 Sep 28;206(10):2285-97. doi: 10.1084/jem.20081940. Epub 2009 Sep 21. J Exp Med. 2009. PMID: 19770270 Free PMC article.

7

Purloined mechanisms of bacterial immunity can cure muscular dystrophy.

Tidball JG, Bertoni C. Tidball JG, et al. Among authors: bertoni c. Cell Metab. 2014 Dec 2;20(6):927-9. doi: 10.1016/j.cmet.2014.11.011. Cell Metab. 2014. PMID: 25470540 Free PMC article.

8

Strand bias in oligonucleotide-mediated dystrophin gene editing.

Bertoni C, Morris GE, Rando TA. Bertoni C, et al. Hum Mol Genet. 2005 Jan 15;14(2):221-33. doi: 10.1093/hmg/ddi020. Epub 2004 Nov 24. Hum Mol Genet. 2005. PMID: 15563511

9

Site-directed gene repair of the dystrophin gene mediated by PNA-ssODNs.

Kayali R, Bury F, Ballard M, Bertoni C. Kayali R, et al. Among authors: bertoni c. Hum Mol Genet. 2010 Aug 15;19(16):3266-81. doi: 10.1093/hmg/ddq235. Epub 2010 Jun 11. Hum Mol Genet. 2010. PMID: 20542988

10

Therapy development for neuromuscular diseases: translating hope into promise.

Bertoni C. Bertoni C. Future Neurol. 2013 Jul 1;8(4):10.2217/fnl.13.29. doi: 10.2217/fnl.13.29. Future Neurol. 2013. PMID: 24273459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year